Covidien's acquisition of Aspect Medical Systems under investigation

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Aspect Medical Systems, Inc. (“Aspect Medical” or the “Company”) (Nasdaq:ASPM), related to the Company’s agreement to be acquired by Covidien plc (“Covidien”) in a cash transaction valued at approximately $210 million, net of cash and short-term investments acquired.

Under the terms of the definitive agreement entered into by the parties, the transaction will take the form of an all-cash tender offer, pursuant to which a wholly owned subsidiary of Covidien will pay $12.00 in cash for each share of Aspect Medical, followed by a second-step merger. The investigation concerns possible breaches of fiduciary duty and other violations of state law related to approval of the transaction by the Aspect Medical board of directors.

If you own shares of Aspect Medical Systems, Inc., if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [email protected].

http://www.aspectmedical.com 

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.